Inside Precision Medicine August 7, 2025
Jonathan D. Grinstein, PhD

Nearly 500,000 participants in the UK Biobank have had their whole-genome sequencing (WGS) data added, making it one of the biggest continuing population-based studies. About 1.5 billion variants—including single nucleotide polymorphisms (SNPs), insertion-deletion (indel) variants, and structural variants (SVs)—have been found in participants of the population-based study. Many of these variants are linked to various disease features and traits and could enable a deeper understanding of disease mechanisms, including those that affect disease risk through non-coding mechanisms.

New dimension of data

The contribution of rare non-coding variation to human diseases and other complex traits has been well-documented. However, research into this area is still in its infancy due to the enormous amounts of data needed from various modalities. Before this...

Today's Sponsors

Venturous
ZeOmega

Today's Sponsor

Venturous

 
Topics: Pharma / Biotech, Precision Medicine
JPM 2026: Genoa Ventures’ Jenny Rooke on Next-Gen Clinical Assessment Tools
From Early Detection to Targeted Therapy: How AI is Reframing Precision Medicine
How Precision Medicine and AI are Evolving: An MD Anderson Perspective
Bringing Precision Medicine Into the Home
Inside the Virtual Cell: New Depths for Precision Medicine

Share Article